Advertisement
Screener

Bellerophon Therapeutics, Inc. Operating Income

Bellerophon Therapeutics, Inc. Operating Income

Bellerophon Therapeutics, Inc. reported Operating Income of -$2.17 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2023-11-14

  • Bellerophon Therapeutics, Inc. operating income (loss) for the quarter ending 2023-09-30 was -$2.17M.
  • Bellerophon Therapeutics, Inc. operating income (loss) for the quarter ending 2023-06-30 was -$5.26M.
  • Bellerophon Therapeutics, Inc. operating income (loss) for the quarter ending 2023-03-31 was $1.48M.
  • Bellerophon Therapeutics, Inc. operating income (loss) for the quarter ending 2022-12-31 was -$5.08M.
  • Bellerophon Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$22.38M.
  • Bellerophon Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$20.16M.
  • Bellerophon Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$26.28M.
  • Bellerophon Therapeutics, Inc. operating income (loss) for fiscal 2019 was -$17.47M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2023-09-30-$2.17M
10-Q · filed 2023-11-14
-$7.43M
derived: sum of 2 quarters · filed 2023-11-14
-$5.95M
10-Q · filed 2023-11-14
-$11.04M
derived: sum of 4 quarters · filed 2023-11-14
2023-06-30-$5.26M
10-Q · filed 2023-08-14
-$3.78M
10-Q · filed 2023-08-14
-$8.87M
derived: sum of 3 quarters · filed 2023-08-14
-$13.98M
derived: sum of 4 quarters · filed 2023-11-14
2023-03-31$1.48M
10-Q · filed 2023-05-15
-$3.61M
derived: sum of 2 quarters · filed 2023-05-15
-$8.72M
derived: sum of 3 quarters · filed 2023-11-14
-$15.26M
derived: sum of 4 quarters · filed 2023-11-14
2022-12-31-$5.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$10.20M
derived: sum of 2 quarters · filed 2023-11-14
-$16.74M
derived: sum of 3 quarters · filed 2023-11-14
-$22.38M
10-K · filed 2023-03-31
2022-09-30-$5.12M
10-Q · filed 2023-11-14
-$11.66M
derived: sum of 2 quarters · filed 2023-11-14
-$17.30M
10-Q · filed 2023-11-14
-$21.57M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$6.54M
10-Q · filed 2023-08-14
-$12.18M
10-Q · filed 2023-08-14
-$16.46M
derived: sum of 3 quarters · filed 2023-08-14
-$21.26M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$5.64M
10-Q · filed 2023-05-15
-$9.91M
derived: sum of 2 quarters · filed 2023-05-15
-$14.72M
derived: sum of 3 quarters · filed 2023-05-15
-$19.94M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$4.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$9.08M
derived: sum of 2 quarters · filed 2023-03-31
-$14.30M
derived: sum of 3 quarters · filed 2023-03-31
-$20.16M
10-K · filed 2023-03-31
2021-09-30-$4.80M
10-Q · filed 2022-11-14
-$10.03M
derived: sum of 2 quarters · filed 2022-11-14
-$15.89M
10-Q · filed 2022-11-14
-$24.03M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$5.23M
10-Q · filed 2022-08-15
-$11.09M
10-Q · filed 2022-08-15
-$19.23M
derived: sum of 3 quarters · filed 2022-08-15
-$27.49M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$5.86M
10-Q · filed 2022-05-11
-$14.01M
derived: sum of 2 quarters · filed 2022-05-11
-$22.27M
derived: sum of 3 quarters · filed 2022-05-11
-$28.02M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$8.15M
10-K · filed 2021-03-11
-$16.41M
derived: sum of 2 quarters · filed 2021-11-15
-$22.17M
derived: sum of 3 quarters · filed 2021-11-15
-$26.28M
10-K · filed 2023-03-31
2020-09-30-$8.26M
10-Q · filed 2021-11-15
-$14.02M
derived: sum of 2 quarters · filed 2021-11-15
-$18.13M
10-Q · filed 2021-11-15
-$22.45M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$5.76M
10-Q · filed 2021-08-05
-$9.87M
10-Q · filed 2021-08-05
-$14.18M
derived: sum of 3 quarters · filed 2021-08-05
-$18.77M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$4.11M
10-Q · filed 2021-05-11
-$8.43M
derived: sum of 2 quarters · filed 2021-05-11
-$13.02M
derived: sum of 3 quarters · filed 2021-05-11
-$17.24M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31-$4.32M
10-K · filed 2021-03-11
-$8.91M
derived: sum of 2 quarters · filed 2021-03-11
-$13.13M
derived: sum of 3 quarters · filed 2021-03-11
-$17.47M
10-K · filed 2022-03-31
2019-09-30-$4.59M
10-K · filed 2021-03-11
-$8.82M
derived: sum of 2 quarters · filed 2021-03-11
-$13.16M
10-Q · filed 2020-11-05
-$17.84M
derived: sum of 4 quarters · filed 2021-03-11
2019-06-30-$4.22M
10-K · filed 2021-03-11
-$8.57M
10-Q · filed 2020-08-05
-$13.25M
derived: sum of 3 quarters · filed 2021-03-11
-$20.08M
derived: sum of 4 quarters · filed 2021-03-11
2019-03-31-$4.34M
10-K · filed 2021-03-11
-$9.03M
derived: sum of 2 quarters · filed 2021-03-11
-$15.86M
derived: sum of 3 quarters · filed 2021-03-11
-$23.73M
derived: sum of 4 quarters · filed 2021-03-11
2018-12-31-$4.68M
10-K · filed 2020-04-06
-$11.52M
derived: sum of 2 quarters · filed 2020-04-06
-$19.39M
derived: sum of 3 quarters · filed 2020-04-06
-$27.88M
10-K · filed 2021-03-11
2018-09-30-$6.83M
10-K · filed 2020-04-06
-$14.70M
derived: sum of 2 quarters · filed 2020-04-06
-$23.20M
10-Q · filed 2019-11-06
-$30.50M
derived: sum of 4 quarters · filed 2020-04-06
2018-06-30-$7.87M
10-K · filed 2020-04-06
-$16.36M
10-Q · filed 2019-08-08
-$23.67M
derived: sum of 3 quarters · filed 2020-04-06
-$29.86M
derived: sum of 4 quarters · filed 2020-04-06
2018-03-31-$8.49M
10-K · filed 2020-04-06
-$15.80M
derived: sum of 2 quarters · filed 2020-04-06
-$21.98M
derived: sum of 3 quarters · filed 2020-04-06
-$28.31M
derived: sum of 4 quarters · filed 2020-04-06
2017-12-31-$7.31M
10-K · filed 2019-03-14
-$13.49M
derived: sum of 2 quarters · filed 2019-03-14
-$19.82M
derived: sum of 3 quarters · filed 2019-03-14
-$24.60M
10-K · filed 2020-04-06
2017-09-30-$6.18M
10-K · filed 2019-03-14
-$12.51M
derived: sum of 2 quarters · filed 2019-03-14
-$17.29M
10-Q · filed 2018-11-07
-$24.58M
derived: sum of 4 quarters · filed 2019-03-14
2017-06-30-$6.32M
10-K · filed 2019-03-14
-$11.11M
10-Q · filed 2018-08-01
-$18.40M
derived: sum of 3 quarters · filed 2019-03-14
-$22.61M
derived: sum of 4 quarters · filed 2019-03-14
2017-03-31-$4.78M
10-K · filed 2019-03-14
-$12.07M
derived: sum of 2 quarters · filed 2019-03-14
-$16.29M
derived: sum of 3 quarters · filed 2019-03-14
-$21.45M
derived: sum of 4 quarters · filed 2019-03-14
2016-12-31-$7.29M
10-K · filed 2018-03-15
-$11.51M
derived: sum of 2 quarters · filed 2018-03-15
-$16.67M
derived: sum of 3 quarters · filed 2018-03-15
-$23.76M
10-K · filed 2019-03-14
2016-09-30-$4.22M
10-K · filed 2018-03-15
-$9.38M
derived: sum of 2 quarters · filed 2018-03-15
-$16.46M
10-Q · filed 2017-11-07
-$27.33M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30-$5.16M
10-K · filed 2018-03-15
-$12.25M
10-Q · filed 2017-08-07
-$23.11M
derived: sum of 3 quarters · filed 2018-03-15
-$34.28M
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31-$7.09M
10-K · filed 2018-03-15
-$17.95M
derived: sum of 2 quarters · filed 2018-03-15
-$29.12M
derived: sum of 3 quarters · filed 2018-03-15
-$40.73M
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31-$10.86M
10-K · filed 2017-03-13
-$22.03M
derived: sum of 2 quarters · filed 2017-03-13
-$33.64M
derived: sum of 3 quarters · filed 2017-03-13
-$46.57M
10-K · filed 2018-03-15
2015-09-30-$11.17M
10-K · filed 2017-03-13
-$22.78M
derived: sum of 2 quarters · filed 2017-03-13
-$35.71M
10-Q · filed 2016-11-08
-$48.49M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$11.61M
10-K · filed 2017-03-13
-$24.54M
10-Q · filed 2016-08-09
-$37.32M
derived: sum of 3 quarters · filed 2017-03-13
-$52.82M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31-$12.93M
10-K · filed 2017-03-13
-$25.71M
derived: sum of 2 quarters · filed 2017-03-13
-$41.21M
derived: sum of 3 quarters · filed 2017-03-13
-$58.17M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31-$12.79M
10-K · filed 2016-03-21
-$28.28M
derived: sum of 2 quarters · filed 2016-03-21
-$45.24M
derived: sum of 3 quarters · filed 2016-03-21
-$59.75M
10-K · filed 2017-03-13
2014-09-30-$15.49M
10-K · filed 2016-03-21
-$32.46M
derived: sum of 2 quarters · filed 2016-03-21
-$46.97M
10-Q · filed 2015-11-12
2014-06-30-$16.96M
10-K · filed 2016-03-21
-$31.47M
10-Q · filed 2015-08-14
2014-03-31-$14.51M
10-K · filed 2016-03-21
2013-12-31-$62.00M
10-K · filed 2016-03-21